Del CLSI al EUCAST, una transición necesaria en los laboratorios españoles

[1]  J. Rodríguez-Baño,et al.  Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae , 2018, Clinical Microbiology Reviews.

[2]  Á. Pascual,et al.  Susceptibility testing and detection of β-lactam resistance mechanisms in Enterobacteriaceae: a multicentre national proficiency study. , 2017, International journal of antimicrobial agents.

[3]  G. Kahlmeter.  EUCAST proposes to change the definition and usefulness of the susceptibility category 'Intermediate'. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[4]  J. Rodríguez,et al.  Cambio de CLSI a EUCAST en la interpretación de la sensibilidad a antimicrobianos: ¿cómo influye en nuestro medio? , 2017 .

[5]  Samir N. Patel,et al.  What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings? , 2015, Antimicrobial Agents and Chemotherapy.

[6]  A. Chowdhary,et al.  Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species , 2015, Antimicrobial Agents and Chemotherapy.

[7]  A. Petersen,et al.  Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica , 2015, Journal of Clinical Microbiology.

[8]  L. Martínez-Martínez,et al.  Challenges to accurate susceptibility testing and interpretation of quinolone resistance in Enterobacteriaceae: results of a Spanish multicentre study. , 2015, The Journal of antimicrobial chemotherapy.

[9]  A. Oliver,et al.  Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved? , 2014, Enfermedades infecciosas y microbiologia clinica.

[10]  Ronald N. Jones,et al.  Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp. , 2014, Diagnostic microbiology and infectious disease.

[11]  G Kahlmeter,et al.  Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  R. Weber,et al.  Change of Antibiotic Susceptibility Testing Guidelines from CLSI to EUCAST: Influence on Cumulative Hospital Antibiograms , 2013, PloS one.

[13]  G. Bloemberg,et al.  Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates. , 2013, The Journal of antimicrobial chemotherapy.

[14]  E. Böttger,et al.  Influence of Clinical Breakpoint Changes from CLSI 2009 to EUCAST 2011 Antimicrobial Susceptibility Testing Guidelines on Multidrug Resistance Rates of Gram-Negative Rods , 2013, Journal of Clinical Microbiology.

[15]  A. Oliver,et al.  Challenges for accurate susceptibility testing, detection and interpretation of β-lactam resistance phenotypes in Pseudomonas aeruginosa: results from a Spanish multicentre study. , 2013, The Journal of antimicrobial chemotherapy.

[16]  M. Cuenca-Estrella,et al.  Estudios de sensibilidad en levaduras. Actualización y novedades , 2013 .

[17]  A P MacGowan,et al.  EUCAST expert rules in antimicrobial susceptibility testing. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[18]  M. Cuenca‐Estrella,et al.  [Antifungal susceptibility testing in yeasts. Update and novelties]. , 2013, Enfermedades infecciosas y microbiologia clinica.

[19]  L. Martínez-Martínez,et al.  [The Spanish antibiogram committee (COESANT), in step with EUCAST]. , 2013, Enfermedades infecciosas y microbiologia clinica.

[20]  G. Daikos,et al.  Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions , 2012, Clinical Microbiology Reviews.

[21]  Luis Martínez-Martínez,et al.  Recomendaciones para la selección de antimicrobianos en el estudio de la sensibilidad in vitro con sistemas automáticos y semiautomáticos , 2007 .

[22]  F. Baquero,et al.  European recommendations for antimicrobial resistance surveillance. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.